Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS Gains 3%; BSE HEALTHCARE Index Down 0.2%
Tue, 2 Jul 15:49

KRSNAA DIAGNOSTICS Gains 3%; BSE HEALTHCARE Index Down 0.2%Image source: Nikada/www.istockphoto.com

KRSNAA DIAGNOSTICS share price has zoomed 3% and is presently trading at Rs 628.9.

Meanwhile, the BSE HEALTHCARE index is at 37,159.3 (down 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 5.2%) and AARTI DRUGS (up 3.1%).

MAX HEALTHCARE INSTITUTE (down 4.4%) and FORTIS HEALTHCARE (down 2.9%) are among the top losers today.

Over the last one year, KRSNAA DIAGNOSTICS has moved up from Rs 567.3 to Rs 628.9, registering a gain of Rs 61.6 (up 10.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 25,634.3 to 37,159.3, registering a gain of 45.0% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 84.8%), Cadila Healthcare (up 83.9%) and Lupin (up 83.8%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 79,441.5 .

The top losers among the BSE Sensex today are Kotak Bank (down 2.4%) and Bharti Airtel (down 2.3%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,117.8 (down 0.1%). Shriram Transport and Kotak Bank are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 63,915.4 to 79,441.5, registering a gain of 15,526.0 points (up 24.3%).

KRSNAA DIAGNOSTICS Financial Update...

KRSNAA DIAGNOSTICS net profit fell 1.0% YoY to Rs 187 million for the quarter ended March 2024, compared to a profit of Rs 189 million a year ago. Net sales rose 24.8% to Rs 1,663 million during the period as against Rs 1,332 million in January-March 2023.

For the year ended March 2023, KRSNAA DIAGNOSTICS reported 9.2% decrease in net profit to Rs 621 million compared to net profit of Rs 684 million during FY22. Revenue of the company grew 7.0% to Rs 4,871 million during FY23.

The current Price to earnings ratio of KRSNAA DIAGNOSTICS, based on rolling 12 month earnings, stands at 35.7.


Equitymaster requests your view! Post a comment on "KRSNAA DIAGNOSTICS Gains 3%; BSE HEALTHCARE Index Down 0.2%". Click here!